Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-26T19:09:46.720Z Has data issue: false hasContentIssue false

Monitoring of patients on high dose antipsychotic medication

Published online by Cambridge University Press:  02 January 2018

Kate Sillifant*
Affiliation:
Unit of Child Mental Health, 12A Clarendon Road, Leeds LS2 9NN
Jacqueline Muir
Affiliation:
Northowram Hospital, Halifax
Mary Crabb
Affiliation:
High Royds Hospital, Menston, West Yorkshire LS29 6AQ
Stephen Read
Affiliation:
Crooked Acres, 1 Spen Lane, Leeds LS5 3EG
*
Correspondence
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

In the light of recently published Royal College of Psychiatrists' guidelines on the use of high dose antipsychotic medication, electrocardiographic and blood investigations were performed on 11 patients with learning disabilities receiving such treatment. All patients had normal electrocardiograms (ECGs). Four patients had asymptomatic low white cell counts and mild anaemia was detected in three individuals. Three patients were hyponatraemic; liver function tests were essentially normal. Issues around routine monitoring of such patients are discussed.

Type
Original Papers
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 1997 The Royal College of Psychiatrists

References

Hirsch, S. & Barnes, T. (1994) Clinical use of high dose neuroleptics. British Journal of Psychiatry, 164, 9496.Google Scholar
Royal College of Psychiatrists (1993) Consensus Statement on the Use of High Dose Antipsychotic Medication (Council Report CR26). London: Royal College of Psychiatrists.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.